| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/21/1999 | US5955593 BH3 interacting domain death agonist |
| 09/21/1999 | US5955589 Gapped 2' modified oligonucleotides |
| 09/21/1999 | US5955585 Catalytic condensation method for the preparation of chlorophyll and bacteriochlorophyll derivatives |
| 09/21/1999 | US5955584 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 09/21/1999 | US5955581 Method for producing a stable polymerized hemoglobin blood-substitute |
| 09/21/1999 | US5955580 Vaccines for nontypable haemophilus influenzae |
| 09/21/1999 | US5955579 Islet-specific homeoprotein and transcriptional regulator of insulin gene expression, HOXB13 |
| 09/21/1999 | US5955578 Synthetic matrix of synthetic polypeptide including amino acid sequence of d-arginine-glycine-aspartic acid, a biodegradable polymer, and optional crosslinking agent; temporary wound healing agent which promotes cell migration |
| 09/21/1999 | US5955577 Method for synthesizing a water-soluble β-sheet forming peptide |
| 09/21/1999 | US5955575 Antagonists of G-protein-coupled receptor |
| 09/21/1999 | US5955574 Analogs of parathyroid hormone |
| 09/21/1999 | US5955573 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 09/21/1999 | US5955572 Structural mimics of RGD-binding sites |
| 09/21/1999 | US5955571 Novel n-branched nucleic acids with non-ribose phosphate backbone; for use in controlling gene expression, antisense agents, viricides, diagnosis, and genetic engineering techniques |
| 09/21/1999 | US5955491 Method for treating osteoporosis |
| 09/21/1999 | US5955449 Diagnosis and treatment of bacterial dysentery |
| 09/21/1999 | US5955441 Genetic inhibition of complement mediated inflammatory response |
| 09/21/1999 | US5955438 Collagen-based matrix |
| 09/21/1999 | US5955437 Use of an anticoagulant as a diagnostic agent |
| 09/21/1999 | US5955433 Method of thrombin inhibition |
| 09/21/1999 | US5955431 Mast cell protease peptide inhibitors |
| 09/21/1999 | US5955429 Human apoptosis-associated protein |
| 09/21/1999 | US5955428 DNA encoding human metallothionein |
| 09/21/1999 | US5955426 Such peptides radiolabeled with a radiosiotope, as well as methods for using such peptides for radiodiagnostic and radiotherapeutic purposes |
| 09/21/1999 | US5955425 Parathyroid hormone analogues for the treatment of osteoporosis |
| 09/21/1999 | US5955422 Production of erthropoietin |
| 09/21/1999 | US5955421 Peptides containing D-2-alkyl-Tryptophan |
| 09/21/1999 | US5955420 Exposing cell comprising rse receptor to exogenous growth arrest-specific gene 6 (gas6) polypeptide to activate receptor; treating neurologic disorders |
| 09/21/1999 | US5955368 Expression system for clostridium species |
| 09/21/1999 | US5955366 Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins |
| 09/21/1999 | US5955365 Introducing polynucleotides into cells |
| 09/21/1999 | US5955359 Method of growing granulocytic ehrlichiae of the Ehrlichia phagocytophila genogroup in promyelocytic leukemia cell culture, and preparing antigens and vaccines of said granulocytic ehrlichiae |
| 09/21/1999 | US5955358 Adjusting nucleic acids to increase binding of encoded antibody by randomly incorporating complementarity determining regions; enhancing immune response |
| 09/21/1999 | US5955356 Nucleic acids, vectors, and host cells including mycobacterium derived sequences |
| 09/21/1999 | US5955354 RAS P21-interacting protein (RGL) and its RAS interacting domain (RID) |
| 09/21/1999 | US5955346 Variants of human prolactin and human placeatal lactogen |
| 09/21/1999 | US5955345 Nucleic acids encoding pancreatic islet cell antigens obtained by molecular cloning |
| 09/21/1999 | US5955343 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| 09/21/1999 | US5955342 Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region |
| 09/21/1999 | US5955341 Heterodimeric receptor libraries using phagemids |
| 09/21/1999 | US5955333 Transferring selectable markers into protozoans or yeast by homologus recombination at specific positions in the genome with the use of a vector; replacement of virulence gene; vacine development |
| 09/21/1999 | US5955332 Polynucleotide sequence that codes for a protein that prevents viral infection of lactic acid bacteria; for production of dairy products and other foods |
| 09/21/1999 | US5955331 Recombinant retroviruses with amphotropic and ecotropic host ranges |
| 09/21/1999 | US5955318 Reagents and methods useful for controlling the translation of hepatitis GBV proteins |
| 09/21/1999 | US5955317 Antibodies to β-amyloids or their derivatives and use thereof |
| 09/21/1999 | US5955316 Recombinant expression plasmid vector for efficient and commerical production includes promoter, signal sequence, and nucleotide sequences of amino-terminus of endogenous aspergillus polypeptide, peptide linker and lactoferrin |
| 09/21/1999 | US5955315 Nucleic acids encoding human interleukin-4 |
| 09/21/1999 | US5955314 Nucleotide sequence that codes polypeptide controller of g-protein signaling; prevention and diagnosis of cancer; anticarcinogenic agents; antiinflammatory agents; therapy of nervous system disorders; antisense agents |
| 09/21/1999 | US5955313 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded uses thereof |
| 09/21/1999 | US5955312 For diagnosis of proliferative disorders; antiproliferative agents; antisense agents |
| 09/21/1999 | US5955311 Monoclonal antibodies specific to VEGF receptors and uses thereof |
| 09/21/1999 | US5955310 Culturing bacillus cell which contains nucleic acid construct having promoter linked to coding sequences and messenger rna processing/stabizing sequence, isolating polypeptide |
| 09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |
| 09/21/1999 | US5955308 cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor |
| 09/21/1999 | US5955307 Plasmid vector and use thereof for the production of interferon |
| 09/21/1999 | US5955306 Nucleotide sequences that codes for a polypeptide that is useful in the development of screening methods, therapeutics and diagnostic tools related to obesity |
| 09/21/1999 | US5955305 Human retinoid binding protein |
| 09/21/1999 | US5955304 DivIB |
| 09/21/1999 | US5955303 Human chemokine receptor-like protein |
| 09/21/1999 | US5955302 Polynucleotide sequence encoding human dosage compensation-associated protein |
| 09/21/1999 | US5955301 Diagonosis, prevention and therapy of central nervous system defects; parkinson's, huntington's and alzheimers's diseases; antiischemic/ antiepileptic agents |
| 09/21/1999 | US5955300 Immunoglobulin fusion protein with amino acid replacements immunosuppressant against autoimmune diseases; useful in the therapeutic treament of melanomas and leukemias |
| 09/21/1999 | US5955299 For diagnosis and treatment of systemic lupus erythematosus; antisense agents |
| 09/21/1999 | US5955298 Sequences for production of 2,4-Diacetylphloroglucinol and methods |
| 09/21/1999 | US5955297 Expression plasmids for improved production of heterologous protein in bacteria |
| 09/21/1999 | US5955294 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 09/21/1999 | US5955292 Antibodies which bind to a polypeptide which can be used as a diagnostic tool to screen for cell propagation disorders |
| 09/21/1999 | US5955291 Antibodies against extrcellular domain; useful as a diagnostic tool of tumor formation; monitoring of wound healing; imaging agents |
| 09/21/1999 | US5955288 Screening for ligands by transforming yeast cells which constitutively express heterologous kinase with complementary dna library, detecting intracellular protein kinase activity |
| 09/21/1999 | US5955286 Method for screening compounds for activities related to insulin receptor binding |
| 09/21/1999 | US5955284 Screening for serine protease inhibitors by using; hybridization detecting complex |
| 09/21/1999 | US5955283 Dna probe useful in diagnosis of diseases related to ion transport in the central and or automonic neverous system; alzheimer's/parkindon's/huntington's diseases |
| 09/21/1999 | US5955281 Screening cells for mutant forms of receptors or signal transduction proteins by transfecting cells with dna library, incubating cells with little or no agonist, measuring levels of marker |
| 09/21/1999 | US5955279 Ataxia-telangiectasia: mutations in the ATM gene |
| 09/21/1999 | US5955278 Polynucleotide sequences coding human protein synthesis controller; useful in diagnosis, prevention, and therapy for apoptosis; antiinflammatory agents; anticarcinogenic agents; antiproliferative agents |
| 09/21/1999 | US5955264 Rapid and simple selection of complementary dna encoding proteinmutations which reduce binding; using expression vectors in host cells exposed to selection agents |
| 09/21/1999 | US5955263 Detecting wild type human oncogene protein in cell; diagnosis and cancer treatment; anticarcinogenic agents |
| 09/21/1999 | US5955260 Antibodies that bind viral proteins that share homogeneity; for diagnostic immunoassay of virus in sample |
| 09/21/1999 | US5955256 Mixing with photosensitizer and blocking agent of cysteine, n-acetylcysteine, dithiothreitol, butylated hydroxytoluene, butylated hydroxyanisole, tyrosine, histidine, tryptophan, propyl gallate, or mercaptopropionyl glycine |
| 09/21/1999 | US5955090 Immunogenic hybrid protein OprF-OprI derived from Pseudomonas aeruginosa membrane proteins |
| 09/21/1999 | US5955089 Streptococcus for vaccines |
| 09/21/1999 | US5955088 Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins |
| 09/21/1999 | US5955087 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
| 09/21/1999 | US5955078 Novel polypeptides and monoclonal antibodies, preparation and use to combat infection at the site of wounds, surgical implants and other in-dwelling devices such as catheters |
| 09/21/1999 | US5955077 Tuberculosis vaccine |
| 09/21/1999 | US5955075 Molecular hybridization, genetic engineering |
| 09/21/1999 | US5955073 Selective RNase cytotoxic reagents |
| 09/21/1999 | US5955072 Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide |
| 09/21/1999 | US5955069 Use of canine interferon-γ(IFN-γ) to treat non-atopic dermatitis |
| 09/21/1999 | US5955055 Detection accumulated peptide with amino acid sequence region of apolipoprotein or elastin; labelling; diagnosing atherosclerosis |
| 09/21/1999 | CA2174971C Neural axon outgrowth modulators |
| 09/21/1999 | CA2145313C Antimicrobial peptides |
| 09/21/1999 | CA2098773C Recombinant coccidia and its use in a vaccine |
| 09/21/1999 | CA2073741C Thromboplastin extract, reagent, and preparation thereof |
| 09/21/1999 | CA2045761C Ws7622a mono- or di- sulfate, process for preparation thereof and use thereof |
| 09/21/1999 | CA2006087C Polypeptides isolated from the venom of the spider hololena curta |
| 09/21/1999 | CA1340762C Recombinant birth control vaccine |
| 09/21/1999 | CA1340761C Interleukin-4-receptors |
| 09/20/1999 | CA2232812A1 Interleukin-1 receptor antagonist beta (il-1ra.beta.) |
| 09/20/1999 | CA2226394A1 A method for influencing chromosome stability |